» Articles » PMID: 37824429

Detection and Clearance of Type-Specific and Phylogenetically Related Genital Human Papillomavirus Infections in Young Women in New Heterosexual Relationships

Overview
Journal J Infect Dis
Date 2023 Oct 12
PMID 37824429
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Understanding the natural history of human papillomavirus (HPV) infections is essential to cervical cancer prevention planning. We estimated HPV type-specific infection detection and clearance in young women.

Methods: The HPV Infection and Transmission among Couples through Heterosexual activity (HITCH) study is a prospective cohort of 502 college-age women who recently initiated a heterosexual relationship. We tested vaginal samples collected at 6 clinical visits over 24 months for 36 HPV types. Using rates and Kaplan-Meier analysis, we estimated time-to-event statistics with 95% confidence intervals (CIs) for detection of incident infections and clearance of incident and present-at-baseline infections (separately). We conducted analyses at the woman- and HPV-levels, with HPV types grouped by phylogenetic relatedness.

Results: By 24 months, we detected incident infections in 40.4% (CI, 33.4%-48.4%) of women. Incident subgenus 1 (43.4; CI, 33.6-56.4), 2 (47.1; CI, 39.9-55.5), and 3 (46.6; CI, 37.7-57.7) infections cleared at similar rates per 1000 infection-months. We observed similar homogeny in HPV-level clearance rates among present-at-baseline infections.

Conclusions: Our analyses provide type-specific infection natural history estimates for cervical cancer prevention planning. HPV-level analyses did not clearly indicate that high oncogenic risk subgenus 2 infections persist longer than their low oncogenic risk subgenera 1 and 3 counterparts.

Citing Articles

Outcomes and associated factors of cervical human papillomavirus infection among 608 women in Shenzhen, China, 2018-2023.

Lv Z, He X, Li Z, Yuan Y, Zhou X, Tu C Front Public Health. 2025; 12:1523839.

PMID: 39877908 PMC: 11772415. DOI: 10.3389/fpubh.2024.1523839.


Breaking barriers: why including boys and men is key to HPV prevention.

Naidoo D, Govender K, Mantell J BMC Med. 2024; 22(1):525.

PMID: 39516809 PMC: 11549739. DOI: 10.1186/s12916-024-03701-8.

References
1.
Wright Jr T, Denny L, Kuhn L, Pollack A, Lorincz A . HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000; 283(1):81-6. DOI: 10.1001/jama.283.1.81. View

2.
Serrano B, de Sanjose S, Tous S, Quiros B, Munoz N, Bosch X . Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer. 2015; 51(13):1732-41. DOI: 10.1016/j.ejca.2015.06.001. View

3.
Giuliano A, Harris R, Sedjo R, Baldwin S, Roe D, Papenfuss M . Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis. 2002; 186(4):462-9. DOI: 10.1086/341782. View

4.
Insinga R, Perez G, Wheeler C, Koutsky L, Garland S, Leodolter S . Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiol Biomarkers Prev. 2010; 19(6):1585-94. DOI: 10.1158/1055-9965.EPI-09-1235. View

5.
Schiffman M, Castle P, Jeronimo J, Rodriguez A, Wacholder S . Human papillomavirus and cervical cancer. Lancet. 2007; 370(9590):890-907. DOI: 10.1016/S0140-6736(07)61416-0. View